LOADING
Tag: Crohn
FDA Approves First Pill to Treat Moderate-to-Severe Crohn Disease – Consumer Health News
May 19, 2023
FRIDAY, May 19, 2023 (HealthDay News) — Patients with Crohn disease have a new treatment option, following U.S. Food and Drug Administration approval of Rinvoq (upadacitinib). Rinvoq is meant to treat adults with moderately to severely active Crohn disease who have not had success with tumor necrosis factor blockers. The daily pill is the first […]
chat_bubble0 Comment
visibility313 Views